EP1187614A4
(fr)
|
1999-06-04 |
2005-06-22 |
Merck & Co Inc |
Piperidines substituees en tant qu'agonistes du recepteur de melanocortine-4
|
US7176279B2
(en)
|
2000-06-28 |
2007-02-13 |
Palatin Technologies, Inc. |
Cyclic peptide compositions and methods for treatment of sexual dysfunction
|
US6579968B1
(en)
*
|
1999-06-29 |
2003-06-17 |
Palatin Technologies, Inc. |
Compositions and methods for treatment of sexual dysfunction
|
AU2004202804B2
(en)
*
|
1999-08-04 |
2009-01-29 |
Ore Pharmaceuticals Inc. |
Melanocortin-4 Receptor Binding Compounds and Methods of use thereof
|
US6699873B1
(en)
|
1999-08-04 |
2004-03-02 |
Millennium Pharmaceuticals, Inc. |
Melanocortin-4 receptor binding compounds and methods of use thereof
|
US7375125B2
(en)
|
1999-08-04 |
2008-05-20 |
Ore Pharmaceuticals, Inc. |
Melanocortin-4 receptor binding compounds and methods of use thereof
|
WO2001010842A2
(fr)
*
|
1999-08-04 |
2001-02-15 |
Millennium Pharmaceuticals, Inc. |
Composes fixant les recepteurs de melanocortine-4 et procedes d'utilisation de ces composes
|
WO2001055107A2
(fr)
*
|
2000-01-28 |
2001-08-02 |
Melacure Therapeutics Ab |
Nouveaux amines et amides aromatiques agissant sur les recepteurs de la melanocortine
|
GB0002059D0
(en)
*
|
2000-01-28 |
2000-03-22 |
Melacure Therapeutics Ab |
Novel aromatic amines
|
CA2403686C
(fr)
|
2000-03-23 |
2010-01-26 |
Merck & Co., Inc. |
Piperidines substituees en tant qu'agonistes du recepteur de la melanocortine
|
US6472398B1
(en)
|
2000-03-23 |
2002-10-29 |
Merck & Co., Inc. |
Spiropiperidine derivatives as melanocortin receptor agonists
|
US6600015B2
(en)
*
|
2000-04-04 |
2003-07-29 |
Hoffmann-La Roche Inc. |
Selective linear peptides with melanocortin-4 receptor (MC4-R) agonist activity
|
AU2001264977B2
(en)
*
|
2000-05-30 |
2005-04-14 |
Merck & Co., Inc. |
Melanocortin receptor agonists
|
CA2413506A1
(fr)
*
|
2000-06-27 |
2002-12-20 |
Taisho Pharmaceutical Co., Ltd. |
Agent therapeutique contre l'anxiete nevrotique ou la depression et derive de piperazine
|
PL360855A1
(en)
*
|
2000-06-28 |
2004-09-20 |
Pfizer Products Inc. |
Melanocortin receptor ligands
|
GB0019357D0
(en)
|
2000-08-07 |
2000-09-27 |
Melacure Therapeutics Ab |
Novel phenyl guanidines
|
GB0019359D0
(en)
*
|
2000-08-07 |
2000-09-27 |
Melacure Therapeutics Ab |
Novel guanidines
|
WO2002015909A1
(fr)
|
2000-08-23 |
2002-02-28 |
Merck & Co., Inc. |
Piperidines substituees en tant qu'agonistes de recepteurs de la melanocortine
|
DZ3415A1
(fr)
*
|
2000-08-31 |
2002-03-07 |
Chiron Corp |
Guanidinobenzamides comme mc4-r agonistes.
|
US7169777B2
(en)
|
2001-01-23 |
2007-01-30 |
Eli Lilly And Company |
Melanocortin receptor agonists
|
CA2433025A1
(fr)
|
2001-01-23 |
2002-08-01 |
Chaoyu Xie |
Piperidines/piperazines substituees utilisees comme agonistes du recepteur de melanocortine
|
WO2002059117A1
(fr)
|
2001-01-23 |
2002-08-01 |
Eli Lilly And Company |
Derives de piperazine et de piperidine en tant qu'agonistes du recepteur de la melanocortine
|
WO2002062766A2
(fr)
*
|
2001-02-07 |
2002-08-15 |
Millennium Pharmaceuticals, Inc. |
Composes de liaison au recepteur de la melanocortine-4 et procedes d'utilisation de tels composes
|
AU2002238106A1
(en)
|
2001-02-13 |
2002-08-28 |
Palatin Technologies, Inc. |
Melanocortin metallopeptides for treatment of sexual dysfunction
|
RS63203A
(en)
|
2001-02-28 |
2006-12-15 |
Merck & Co.Inc. |
Acylated piperidine derivatives as melanocortin-4 receptor agonists
|
US7012084B2
(en)
|
2001-02-28 |
2006-03-14 |
Merck & Co., Inc. |
Acylated piperidine derivatives as melanocortin-4 receptor agonists
|
EP1363631A4
(fr)
*
|
2001-03-02 |
2005-11-16 |
Bristol Myers Squibb Co |
Composes utiles comme modulateurs des recepteurs de la melanocortine et compositions pharmaceutiques renfermant ceux-ci
|
WO2002081443A1
(fr)
|
2001-04-09 |
2002-10-17 |
Chiron Corporation |
Nouveaux composes guanidino
|
US6911447B2
(en)
|
2001-04-25 |
2005-06-28 |
The Procter & Gamble Company |
Melanocortin receptor ligands
|
US6809104B2
(en)
|
2001-05-04 |
2004-10-26 |
Tularik Inc. |
Fused heterocyclic compounds
|
WO2002094825A1
(fr)
*
|
2001-05-22 |
2002-11-28 |
Banyu Pharmaceutical Co., Ltd. |
Nouveau derive de spiropiperidine
|
US7115628B2
(en)
|
2001-07-18 |
2006-10-03 |
Merck & Co., Inc. |
Bridged piperidine derivatives as melanocortin receptor agonists
|
US7115607B2
(en)
*
|
2001-07-25 |
2006-10-03 |
Amgen Inc. |
Substituted piperazinyl amides and methods of use
|
WO2003013571A1
(fr)
|
2001-08-10 |
2003-02-20 |
Palatin Technologies, Inc. |
Peptidomimetiques de metallopeptides biologiquement actifs
|
HUP0202719A3
(en)
*
|
2001-08-21 |
2006-01-30 |
Pfizer Prod Inc |
Pharmaceutical compositions for the treatment of female sexual dysfunctions
|
KR20030027439A
(ko)
*
|
2001-09-28 |
2003-04-07 |
주식회사 엘지생명과학 |
멜라노코틴 수용체의 항진제
|
US6916812B2
(en)
|
2001-10-09 |
2005-07-12 |
Bristol-Myers Squibb Company |
Alpha-aminoamide derivatives as melanocortin agonists
|
UA78974C2
(en)
|
2001-10-20 |
2007-05-10 |
Boehringer Ingelheim Pharma |
Use of flibanserin for treating disorders of sexual desire
|
US10675280B2
(en)
|
2001-10-20 |
2020-06-09 |
Sprout Pharmaceuticals, Inc. |
Treating sexual desire disorders with flibanserin
|
KR20030035592A
(ko)
*
|
2001-10-31 |
2003-05-09 |
주식회사 엘지생명과학 |
멜라노코틴 수용체의 항진제
|
KR20030035589A
(ko)
*
|
2001-10-31 |
2003-05-09 |
주식회사 엘지생명과학 |
멜라노코틴 수용체의 항진제
|
US7319107B2
(en)
|
2001-11-08 |
2008-01-15 |
Johnson & Johnson Consumer Companies, Inc. |
1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
|
JP4436676B2
(ja)
|
2001-11-08 |
2010-03-24 |
オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド |
メラノコルチン受容体調節剤としての新規な1,2,4−チアジアゾール誘導体
|
WO2003061660A1
(fr)
*
|
2002-01-23 |
2003-07-31 |
Eli Lilly And Company |
Agonistes du recepteur de la melanocortine
|
US20030207814A1
(en)
*
|
2002-02-04 |
2003-11-06 |
Chiron Corporation |
Novel guanidinyl derivatives
|
US7026335B2
(en)
|
2002-04-30 |
2006-04-11 |
The Procter & Gamble Co. |
Melanocortin receptor ligands
|
MXPA04011093A
(es)
*
|
2002-05-10 |
2005-02-14 |
Neurocrine Biosciences Inc |
Piperazina sustituida como ligandos de receptores de melanocortina.
|
MXPA04011557A
(es)
|
2002-05-23 |
2005-07-05 |
Chiron Corp |
Compuestos de quinazolinona sustituida.
|
GB0213715D0
(en)
|
2002-06-14 |
2002-07-24 |
Syngenta Ltd |
Chemical compounds
|
US7105526B2
(en)
|
2002-06-28 |
2006-09-12 |
Banyu Pharmaceuticals Co., Ltd. |
Benzimidazole derivatives
|
BR0305628A
(pt)
|
2002-07-09 |
2004-09-08 |
Palatin Technologies Inc |
Composição farmacêutica para tratar disfunção sexual num mamìfero compreendendo peptìdeo e seu uso
|
AU2003268493A1
(en)
|
2002-09-11 |
2004-04-30 |
Merck & Co., Inc. |
Piperazine urea derivatives as melanocortin-4 receptor agonists
|
US7045527B2
(en)
|
2002-09-24 |
2006-05-16 |
Amgen Inc. |
Piperidine derivatives
|
US7132539B2
(en)
|
2002-10-23 |
2006-11-07 |
The Procter & Gamble Company |
Melanocortin receptor ligands
|
CA2505372A1
(fr)
|
2002-11-06 |
2004-05-27 |
Tularik Inc. |
Composes heterocycliques condenses
|
US7323462B2
(en)
|
2002-12-10 |
2008-01-29 |
Pfizer Inc. |
Morpholine dopamine agonists
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
US7160886B2
(en)
|
2003-03-03 |
2007-01-09 |
Merck & Co., Inc. |
Acylated piperazine derivatives as melanocortin-4 receptor agonists
|
EP1460073A1
(fr)
*
|
2003-03-20 |
2004-09-22 |
MyoContract Ltd. |
Dérivés substitués de la pipéridine et la pipérazine comme modulateurs du récepteur de la melanocortine-4
|
JP2006521359A
(ja)
|
2003-03-26 |
2006-09-21 |
メルク エンド カムパニー インコーポレーテッド |
メラノコルチン−4受容体作働薬としての二環式ピペリジン誘導体
|
CA2520114A1
(fr)
|
2003-04-04 |
2004-10-21 |
Merck & Co., Inc. |
Derives de spiropiperidine acyles utilises comme agonistes vis-a-vis du recepteur de melanocortine-4
|
US7049323B2
(en)
|
2003-04-25 |
2006-05-23 |
Bristol-Myers Squibb Company |
Amidoheterocycles as modulators of the melanocortin-4 receptor
|
CA2523015A1
(fr)
|
2003-05-23 |
2004-12-29 |
Chiron Corporation |
Composes de quinazoline substitues par guanidino constituant des agonistes de mc4-r
|
CN1902177A
(zh)
|
2003-09-22 |
2007-01-24 |
万有制药株式会社 |
新哌啶衍生物
|
AU2004293012A1
(en)
|
2003-11-19 |
2005-06-09 |
Rustum S. Boyce |
Quinazolinone compounds with reduced bioaccumulation
|
US7420059B2
(en)
|
2003-11-20 |
2008-09-02 |
Bristol-Myers Squibb Company |
HMG-CoA reductase inhibitors and method
|
GB0328906D0
(en)
|
2003-12-12 |
2004-01-14 |
Syngenta Participations Ag |
Chemical compounds
|
GB0328908D0
(en)
|
2003-12-12 |
2004-01-14 |
Syngenta Participations Ag |
Chemical compounds
|
GB0328907D0
(en)
|
2003-12-12 |
2004-01-14 |
Syngenta Participations Ag |
Chemical compounds
|
CN1938286A
(zh)
|
2004-03-29 |
2007-03-28 |
默克公司 |
作为11-β-羟甾类脱氢酶-1抑制剂的二芳基三唑
|
US20080125403A1
(en)
|
2004-04-02 |
2008-05-29 |
Merck & Co., Inc. |
Method of Treating Men with Metabolic and Anthropometric Disorders
|
US7618987B2
(en)
|
2004-07-19 |
2009-11-17 |
Merck & Co., Inc. |
Acylated piperidine derivatives as melanocortin 4-receptor agonists
|
ATE472531T1
(de)
|
2004-08-06 |
2010-07-15 |
Merck Sharp & Dohme |
Sulfonylverbindungen als hemmer von 11-beta- hydroxysteroiddehydrogenase-1
|
EP1892241B1
(fr)
|
2005-05-30 |
2016-03-30 |
Msd K.K. |
Nouveau derive de piperidine
|
US20070021433A1
(en)
|
2005-06-03 |
2007-01-25 |
Jian-Qiang Fan |
Pharmacological chaperones for treating obesity
|
US8227476B2
(en)
|
2005-08-03 |
2012-07-24 |
Sprout Pharmaceuticals, Inc. |
Use of flibanserin in the treatment of obesity
|
JPWO2007018248A1
(ja)
|
2005-08-10 |
2009-02-19 |
萬有製薬株式会社 |
ピリドン化合物
|
EP1921065B1
(fr)
|
2005-08-24 |
2010-10-20 |
Banyu Pharmaceutical Co., Ltd. |
Dérivé phénylpyridone
|
JPWO2007029847A1
(ja)
|
2005-09-07 |
2009-03-19 |
萬有製薬株式会社 |
二環性芳香族置換ピリドン誘導体
|
KR20080048502A
(ko)
|
2005-09-29 |
2008-06-02 |
머크 앤드 캄파니 인코포레이티드 |
멜라노코르틴-4 수용체 조절제로서의 아실화스피로피페리딘 유도체
|
WO2007047496A2
(fr)
|
2005-10-18 |
2007-04-26 |
Merck & Co., Inc. |
Derives de spiropiperidine acyles utilises en tant que modulateurs vis-a-vis du recepteur de melanocortine-4
|
EP1940374A2
(fr)
|
2005-10-21 |
2008-07-09 |
Novartis AG |
Combinaison d'un inhibiteur de la renine avec un agent anti-dyslipidemique et/ou un agent anti-obesite
|
CA2627139A1
(fr)
|
2005-10-27 |
2007-05-03 |
Banyu Pharmaceutical Co., Ltd. |
Nouveau derive de benzoxathiine
|
BRPI0618354B8
(pt)
|
2005-11-10 |
2021-05-25 |
Banyu Pharma Co Ltd |
composto e seu uso, composição farmacêutica, preventivo ou remédio
|
EP1801098A1
(fr)
|
2005-12-16 |
2007-06-27 |
Merck Sante |
Dérivés de 2-Adamantylurea comme inhibiteurs de 11B-HSD1
|
JP2009521483A
(ja)
|
2005-12-22 |
2009-06-04 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
ムスカリン受容体のモジュレーター
|
WO2007100664A2
(fr)
*
|
2006-02-22 |
2007-09-07 |
Vertex Pharmaceuticals Incorporated |
Modulateurs des récepteurs muscariniques
|
EP1987034B1
(fr)
|
2006-02-22 |
2011-07-20 |
Vertex Pharmceuticals Incorporated |
Modulateurs des recepteurs muscariniques
|
EP2348016B1
(fr)
|
2006-06-09 |
2016-02-17 |
SynAct Pharma ApS |
Dérivés de phényl pyrrole aminoguanidin
|
EP2040706A2
(fr)
|
2006-06-29 |
2009-04-01 |
Vertex Pharmceuticals Incorporated |
Modulateurs des récepteurs muscariniques
|
ATE456369T1
(de)
|
2006-06-30 |
2010-02-15 |
Boehringer Ingelheim Int |
Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
|
CA2660903A1
(fr)
|
2006-08-15 |
2008-02-21 |
Vertex Pharmaceuticals Incorporated |
Modulateurs de recepteurs muscariniques
|
CA2770486C
(fr)
|
2006-09-22 |
2014-07-15 |
Merck Sharp & Dohme Corp. |
Utilisation de la platencine et de la platensimycine en tant qu'inhibiteurs de la synthese des acides gras pour traiter l'obesite, lediabete et le cancer
|
WO2008039418A2
(fr)
*
|
2006-09-27 |
2008-04-03 |
Merck & Co., Inc. |
Dérivés de pipéridine acylés utilisés en tant que modulateurs du récepteur de la mélanocortine-4
|
WO2008039863A2
(fr)
*
|
2006-09-27 |
2008-04-03 |
Braincells, Inc. |
Modulation de la neurogenèse médiée par le récepteur de la mélanocortine
|
US20090247560A1
(en)
|
2006-09-28 |
2009-10-01 |
Banyu Pharmaceutical Co., Ltd. |
Diaryl ketimine derivative
|
WO2008056687A1
(fr)
*
|
2006-11-09 |
2008-05-15 |
Daiichi Sankyo Company, Limited |
Nouveau dérivé de spiropipéridine
|
GB0624987D0
(en)
|
2006-12-14 |
2007-01-24 |
Acure Pharma Ab |
Novel aminoguanidines as melanocortin receptor ligands
|
EP1935420A1
(fr)
|
2006-12-21 |
2008-06-25 |
Merck Sante |
Dérivés du 2-adamantyl-butyramide en tant qu'inhibiteurs selectifs de la 11beta-HSD1
|
US8106086B2
(en)
|
2007-04-02 |
2012-01-31 |
Msd K.K. |
Indoledione derivative
|
ES2393885T7
(es)
|
2007-06-04 |
2014-01-30 |
Synergy Pharmaceuticals Inc. |
Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
CL2008002693A1
(es)
|
2007-09-12 |
2009-10-16 |
Boehringer Ingelheim Int |
Uso de flibanserina para el tratamiento de sintomas vasomotores seleccionados de sofocos, sudores nocturnos, cambios de estado de animo e irritabilidad
|
EP2278962B1
(fr)
|
2008-02-21 |
2014-02-12 |
Janssen Pharmaceutica N.V. |
Procédés de traitement de troubles dermatologiques
|
AU2009220605A1
(en)
|
2008-03-06 |
2009-09-11 |
Msd K.K. |
Alkylaminopyridine derivative
|
JPWO2009119726A1
(ja)
|
2008-03-28 |
2011-07-28 |
Msd株式会社 |
メラニン凝集ホルモン受容体拮抗作用を有するジアリールメチルアミド誘導体
|
EP2110374A1
(fr)
|
2008-04-18 |
2009-10-21 |
Merck Sante |
Dérivés de benzofurane, benzothiophène, benzothiazol en tant que modulateurs FXR
|
WO2009149279A2
(fr)
|
2008-06-04 |
2009-12-10 |
Synergy Pharmaceuticals Inc. |
Agonistes de guanylate cyclase utile dans le traitement de troubles gastro-intestinaux, d'une inflammation, d'un cancer et d'autres troubles
|
US20110071129A1
(en)
|
2008-06-19 |
2011-03-24 |
Makoto Ando |
Spirodiamine-diaryl ketoxime derivative
|
ES2624828T3
(es)
|
2008-07-16 |
2017-07-17 |
Synergy Pharmaceuticals Inc. |
Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
|
CA2731358A1
(fr)
|
2008-07-30 |
2010-02-04 |
Banyu Pharmaceutical Co., Ltd. |
Derive de cycloalkylamine a anneau condense compose de 5/5 ou 5/6 membres
|
WO2010047982A1
(fr)
|
2008-10-22 |
2010-04-29 |
Merck Sharp & Dohme Corp. |
Nouveaux dérivés de benzimidazole cycliques utiles comme agents anti-diabétiques
|
JP5557845B2
(ja)
|
2008-10-31 |
2014-07-23 |
メルク・シャープ・アンド・ドーム・コーポレーション |
糖尿病用剤として有用な新規環状ベンゾイミダゾール誘導体
|
EP2358200A4
(fr)
|
2008-11-17 |
2012-05-16 |
Merck Sharp & Dohme |
Amines bicycliques substituées pour le traitement du diabète
|
CA2686480A1
(fr)
|
2008-12-15 |
2010-06-15 |
Boehringer Ingelheim International Gmbh |
Nouveaux sels
|
WO2011011506A1
(fr)
|
2009-07-23 |
2011-01-27 |
Schering Corporation |
Composés oxazépine spirocyclique en tant qu'inhibiteurs de la stéaroyl-coenzyme a delta-9 désaturase
|
CA2768577A1
(fr)
|
2009-07-23 |
2011-01-27 |
Schering Corporation |
Composes d?oxazepine benzofusionnes en tant qu?inhibiteurs de la coenzyme-stearoyle a delta-9 desaturase
|
AU2010317842A1
(en)
|
2009-11-16 |
2012-07-12 |
Mellitech |
[1,5]-diazocin derivatives
|
JP5540454B2
(ja)
|
2009-12-30 |
2014-07-02 |
シャンハイ フォチョン ファーマシューティカル カンパニー リミテッド |
ジペプチジルペプチダーゼ阻害剤
|
AU2011212478B2
(en)
|
2010-02-05 |
2014-11-06 |
Intervet International B.V. |
Spiroindoline Compounds For Use as Anthelminthics
|
WO2011106273A1
(fr)
|
2010-02-25 |
2011-09-01 |
Merck Sharp & Dohme Corp. |
Nouveaux dérivés benzimidazole cycliques utiles comme agents antidiabétiques
|
WO2011137024A1
(fr)
|
2010-04-26 |
2011-11-03 |
Merck Sharp & Dohme Corp. |
Nouveaux inhibiteurs de spiropipéridine prolylcarboxypeptidase
|
US9365539B2
(en)
|
2010-05-11 |
2016-06-14 |
Merck Sharp & Dohme Corp. |
Prolylcarboxypeptidase inhibitors
|
EP2579873A4
(fr)
|
2010-06-11 |
2013-11-27 |
Merck Sharp & Dohme |
Nouveaux inhibiteurs de prolylcarboxypeptidase
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
US9018395B2
(en)
|
2011-01-27 |
2015-04-28 |
Université de Montréal |
Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators
|
MY159058A
(en)
|
2011-02-25 |
2016-12-15 |
Merck Sharp & Dohme |
Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agent
|
EP2739626B1
(fr)
|
2011-08-04 |
2016-05-04 |
Intervet International B.V. |
Nouveaux composés de spiroindoline
|
JP2015525782A
(ja)
|
2012-08-02 |
2015-09-07 |
メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. |
抗糖尿病性三環式化合物
|
AU2014219020A1
(en)
|
2013-02-22 |
2015-07-23 |
Merck Sharp & Dohme Corp. |
Antidiabetic bicyclic compounds
|
EP2970119B1
(fr)
|
2013-03-14 |
2021-11-03 |
Merck Sharp & Dohme Corp. |
Nouveaux dérivés d'indole utiles en tant qu'agents antidiabétiques
|
WO2014151200A2
(fr)
|
2013-03-15 |
2014-09-25 |
Synergy Pharmaceuticals Inc. |
Compositions utiles pour le traitement de troubles gastro-intestinaux
|
WO2014151206A1
(fr)
|
2013-03-15 |
2014-09-25 |
Synergy Pharmaceuticals Inc. |
Agonistes de la guanylate cyclase et leurs utilisations
|
RS65632B1
(sr)
|
2013-06-05 |
2024-07-31 |
Bausch Health Ireland Ltd |
Ultra-prečišćeni agonisti guanilat-ciklaze c, postupak njihove pripreme i upotrebe
|
WO2015051496A1
(fr)
|
2013-10-08 |
2015-04-16 |
Merck Sharp & Dohme Corp. |
Composés tricycliques antidiabétiques
|
EP3065757A4
(fr)
|
2013-10-09 |
2017-08-23 |
Synergy Pharmaceuticals Inc. |
Agonistes de guanylate cyclase utiles pour la régulation négative de cytokines pro-inflammatoires
|
EP2881391A1
(fr)
|
2013-12-05 |
2015-06-10 |
Bayer Pharma Aktiengesellschaft |
Dérivés de carbocycle spiroindoline et leurs compositions pharmaceutiques
|
WO2016030534A1
(fr)
|
2014-08-29 |
2016-03-03 |
Tes Pharma S.R.L. |
Inhibiteurs de la semialdéhyde décarboxylase de l'acide alpha-amino-bêta-carboxymuconique
|
GB201519196D0
(en)
|
2015-10-30 |
2015-12-16 |
Heptares Therapeutics Ltd |
CGRP Receptor Antagonists
|
GB201519195D0
(en)
|
2015-10-30 |
2015-12-16 |
Heptares Therapeutics Ltd |
CGRP Receptor Antagonists
|
GB201519194D0
(en)
|
2015-10-30 |
2015-12-16 |
Heptares Therapeutics Ltd |
CGRP receptor antagonists
|
US10294214B2
(en)
|
2016-06-07 |
2019-05-21 |
Vanderbilt University |
Positive allosteric modulators of human melanocortin-4 receptor
|
WO2018069532A1
(fr)
|
2016-10-14 |
2018-04-19 |
Tes Pharma S.R.L. |
Inhibiteurs de la semialdéhyde décarboxylase de l'acide alpha-amino-bêta-carboxymuconique
|
US11072602B2
(en)
|
2016-12-06 |
2021-07-27 |
Merck Sharp & Dohme Corp. |
Antidiabetic heterocyclic compounds
|
US10968232B2
(en)
|
2016-12-20 |
2021-04-06 |
Merck Sharp & Dohme Corp. |
Antidiabetic spirochroman compounds
|
KR20210111248A
(ko)
|
2018-11-20 |
2021-09-10 |
테스 파마 에스.알.엘. |
α-아미노-β-카르복시뮤콘산 세미알데하이드 데카르복실라제의 저해제
|
US20230126662A1
(en)
|
2019-12-23 |
2023-04-27 |
Crinetics Pharmaceuticals, Inc. |
Spirocyclic piperidine melanocortin subtype-2 receptor (mc2r) antagonists and uses thereof
|